Cargando…
Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype
INTRODUCTION: Despite intensive study of the mechanisms of chemotherapeutic drug resistance in human breast cancer, few reports have systematically investigated the mechanisms that underlie resistance to the chemotherapy-sensitizing agent tumor necrosis factor (TNF)-α. Additionally, the relationship...
Autores principales: | Zhou, Changhua, Nitschke, Ashley M, Xiong, Wei, Zhang, Qiang, Tang, Yan, Bloch, Michael, Elliott, Steven, Zhu, Yun, Bazzone, Lindsey, Yu, David, Weldon, Christopher B, Schiff, Rachel, McLachlan, John A, Beckman, Barbara S, Wiese, Thomas E, Nephew, Kenneth P, Shan, Bin, Burow, Matthew E, Wang, Guangdi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656902/ https://www.ncbi.nlm.nih.gov/pubmed/19087274 http://dx.doi.org/10.1186/bcr2210 |
Ejemplares similares
-
MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
por: Antoon, James W., et al.
Publicado: (2013) -
Constitutive activation of MEK5 promotes a mesenchymal and migratory cell
phenotype in triple negative breast cancer
por: Matossian, Margarite D., et al.
Publicado: (2021) -
The MEK5/ERK5 Pathway in Health and Disease
por: Paudel, Rupesh, et al.
Publicado: (2021) -
Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress
por: Tusa, Ignazia, et al.
Publicado: (2023) -
MEKK3-MEK5-ERK5 signaling promotes mitochondrial degradation
por: Craig, Jane E., et al.
Publicado: (2020)